Rate My Professor Thet Htar

Dr. Thet Thet Htar is a Senior Lecturer in the Malaysia School of Pharmacy at Monash University. She graduated with a Bachelor of Pharmacy (Honours) in 1999 from the University of Wales in Cardiff, United Kingdom, with a project on the design and synthesis of a novel nucleoside as a potential anti-HIV agent. She completed pre-registration training at West Wales General Hospital in Carmarthen, Wales, and registered as a pharmacist and member of the Royal Pharmaceutical Society of Great Britain in 2000. Htar earned her PhD in Medicinal Chemistry from Cardiff University in 2004, focusing on the design and synthesis of conformationally restrained bicyclic nucleosides as potential antiviral agents. From 2000 to 2003, she served as a sessional community pharmacist in several United Kingdom pharmacies for continuing professional development. In 2004, she was appointed academic lecturer in medicinal chemistry at the School of Pharmacy, Faculty of Medical Sciences, UCSI University, Malaysia. She joined Monash University Malaysia in 2009 as an academic researcher, advancing to Senior Lecturer. Her research interests include small molecule synthesis, molecular docking and simulation studies, and molecular imaging, currently bridging multidisciplinary breast cancer research. Key areas encompass medicinal chemistry, organic synthesis, natural products, drug design for antiviral and anticancer agents, molecular dynamics, GPER, and estrogen receptors. She teaches undergraduate pharmacy students in units involving medicinal chemistry, physical chemistry, and organic chemistry.

Htar has received the MUPA Supervisor of the Year Award in 2018, 2020, 2024, and 2025. Since 2017, she has supervised seven PhD students and one Master's student, with two PhD and one Master's completions under her guidance. Notable publications include 'In Silico Analysis of Curcumin and Its Analogs MS13 and MS17 Against HSF1 and HSP Family Proteins' (2025, Chemistry), 'Pharmacophore-based virtual screening, molecular docking and molecular dynamics studies for the discovery of novel neuraminidase inhibitors' (2024, Journal of Biomolecular Structure and Dynamics), 'Thiadiazine thione derivatives as anti-leishmanial agents' (2024, Journal of Biomolecular Structure and Dynamics), 'Unveiling the power of phytochemicals: Virtual screening of phytochemicals' (2024, Computational Phytochemistry), and 'Computer-aided drug designing illuminate polypharmacology of natural products against multiple estrogen receptor' (2023, Computational Approaches in Drug Discovery, Development and Systems Pharmacology). Her work supports advancements in computational drug discovery for oncology and infectious diseases.